GSK vs UPST · P/E 13, $103.31B cap vs P/E 74, rev $672.9M
GlaxoSmithKline PLC ADR (GSK) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the GSK and UPST stock pages for the full models.
Not investment advice.